Sisters diagnosed weeks apart fight breast cancer together

The "Page Sisters," as some of their friends like to call them, found out soon after their diagnosis that they have the BRCA2 gene, a mutation that puts a woman at a much greater risk for breast and ovarian cancers.

BRCA mutations, which stands for breast cancer susceptibility gene, are most commonly found in women of Ashkenazi Jewish descent, although some northern European populations also have a higher risk of inheriting one of the mutated genes.

Adam Cohen, a doctor at the University of Utah's Huntsman Cancer Institute, said the gene can increase the risk of breast cancer tenfold.

The news prompted Sharee Page to get herself checked, and the same doctor soon diagnosed her with Stage 2 breast cancer.

After the six-hour session, they experience a myriad of matching chemo side effects, including nausea, bloody noses, neuropathy and headaches.

Annette Page's cancer has spread to her lymph nodes, so unlike her sister, she will have to undergo radiation therapy next.